Integra LifeSciences Q2 FY26 GAAP EPS turns to profit at $0.06; revenue rises 0.8% to $418.8 million - IART News | RalliesIntegra LifeSciences Q2 FY26 GAAP EPS turns to profit at $0.06; revenue rises 0.8% to $418.8 million
I
IART• Quarterly results
- Integra LifeSciences posted Q2 revenue of $418.8 million, up 0.8% from a year earlier.
- GAAP net income swung to $4.5 million; GAAP diluted EPS was $0.06.
- GAAP gross margin widened 2.1 percentage points to 52.5%.
- Adjusted EBITDA rose to $78.4 million, lifting margin to 18.7%.
Operational update
- The company said it started production at the Braintree facility.
- It remains on track for a planned Q4 relaunch of SurgiMend.
PSQH
•
